Pfizer, Moderna to reap billions from Covid-19 vaccine booster market

United States News News

Pfizer, Moderna to reap billions from Covid-19 vaccine booster market
United States Latest News,United States Headlines
  • 📰 SowetanLIVE
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

For several months, the companies have said they expect that fully inoculated people will need an extra dose of their vaccines to maintain protection over time and to fend off new coronavirus variants.

The vaccine makers say evidence of waning antibody levels in vaccinated people after six months, as well as an increasing rate of breakthrough infections in countries hit by the Delta variant, support the need for booster shots.

“We don't know what the market forces will be,” Moderna president Stephen Hoge said in an interview last week. “At some point, this will become a more traditional market — we'll look at what are the populations at risk, what value are we creating, and what are the number of products that serve that value. That will ultimately impact price.”

Flu shots cost about $18 to $25 a dose, according to US government data and competition has kept price increases in check, with producers raising prices 4 or 5% in 2021. “A lot of these firms aren't even in the market yet. I think within a year's time, all these companies will have booster strategies,” said Morningstar analyst Damien Conover, who covers Pfizer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SowetanLIVE /  🏆 13. in ZA

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer, Moderna expected to reap billions from Covid vaccine booster marketDrugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from Covid-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come.
Read more »

Joe Phaahla urged to get backup vaccines for Pfizer and J&JEffort must be made to secure AstraZeneca and Sinovac Biotech vaccines in the event of a potential shortage of the Pfizer and J&J doses
Read more »

Pfizer, Moderna expected to reap billions from Covid vaccine booster marketDrugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from Covid-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come.
Read more »

Vaccinated people urged to report all severe side-effectsThat was the plea on Friday from Prof Hannelie Meyer, the head of the SA Vaccination and Immunisation Centre (Savic) at Sefako Makgatho Health Sciences University in Pretoria.
Read more »

Places across the world where you might have to show proof of vaccinationIn South Africa, the Covid-19 vaccine is not mandatory, however, demonstrating your Covid-19 status in certain countries may be required in some circumstances. covid travel vaccination
Read more »

LIVESTREAM | Health Dept briefs media on COVID-19 vaccine rolloutLIVESTREAM | Health Dept briefs media on COVID-19 vaccine rolloutHealth Minister Joe Phaahla and Deputy Health Minister Sibongiseni Dhlomo brief media on South Africa's COVID-19 vaccine rollout.
Read more »



Render Time: 2025-04-13 14:15:33